Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Bram L. T. Ramaekers, Robert F. Wolff, Xavier Pouwels, Marije Oosterhoff, Anoukh Van Giessen, Gill Worthy, Caro Noake, Nigel Armstrong, Jos Kleijnen, Manuela A. Joore

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)917-927
Number of pages11
JournalPharmacoeconomics
Volume36
Issue number8
DOIs
Publication statusPublished - 1 Aug 2018

Cite this